Skip to main content
. 2023 Jan 26;14:1088187. doi: 10.3389/fmicb.2023.1088187

Figure 1.

Figure 1

(A) Difference in the Shannon diversity index of the intestinal bacterial community between healthy controls and patients before and after metformin or liraglutide treatment. (B) Difference in the Chao richness index of the intestinal bacterial community between healthy controls and patients before and after metformin or liraglutide treatment. (C) β-diversity of the intestinal bacterial community in healthy controls and patients before and after metformin or liraglutide treatment. Different letters indicate significant differences between groups. p value < 0.05 indicates that the differences are significant. “**” and “***” indicate significant differences at the levels of 0.01 and 0.001.